Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations

Movement Disorders

Volumn 24, Issue 16, 2009, Pages 2442-2443

  Sammler, Esther M ^a   Swingler, Robert J ^a   Stuart, Arlene ^a   Muqit, Miratul ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LEVODOPA; PARKIN; ROPINIROLE; ROTIGOTINE;

ADULT; ALLELE; APPLICATION SITE RASH; BRADYKINESIA; CASE REPORT; DOPAMINE DYSREGULATION SYNDROME; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; EXON; GASTROINTESTINAL DISEASE; GENE DELETION; GENE MUTATION; HUMAN; HYPERSEXUALITY; INSOMNIA; IRRITABILITY; LETTER; MOOD DISORDER; PARKINSONISM; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; VERBAL HOSTILITY;

ADULT; DOPAMINE; DOPAMINE AGONISTS; HUMANS; MALE; METABOLIC DISEASES; MUTATION; PARKINSONIAN DISORDERS; TETRAHYDRONAPHTHALENES; THIOPHENES; UBIQUITIN-PROTEIN LIGASES;

EID: 73949096723     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22859     Document Type: Letter

References (7)

1. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000;342:1560-1567.
2. Bertoli-Avella AM, Giroud-Benitez JL, Akyol A, et al. Novel parkin mutations detected in patients with early-onset Parkinson's disease. Mov Disord 2005;20:424-431.
3. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003;54:176-185.
4. Lohmann E, Thobois S, Lesage S, et al. A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology 2009;72:110-116.
5. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-1292.
6. O'Sullivan SS, Evans AH, Lees AJ. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 2009;23:157-170.
7. Scherfler C, Khan NL, Pavese N, et al. Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations. Mov Disord 2006;21:783-788.